| Samuel A Mickelson, MD | |
|
960 Johnson Ferry Rd, Suite 200, Atlanta, GA 30342 | |
| (404) 943-0900 | |
| (404) 943-1390 |
| Full Name | Samuel A Mickelson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 42 Years |
| Location | 960 Johnson Ferry Rd, Atlanta, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467410977 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 041173 (Georgia) | Secondary |
| 207YS0012X | Otolaryngology - Sleep Medicine | 041173 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Ear Nose And Throat Associates Pc | 2860443322 | 6 |
News Archive
About 40 percent of Los Angeles County residents say they get no more than 10 minutes of continuous physical activity each week, according to a new report.
A major issue in the development of regenerative medicine is the cell sources used to rebuild damaged tissues.
In an analysis just released it is revealed that with an effective health IT system in place Australia would save up to 5,000 deaths and prevent two million GP and outpatient visits and 310,000 hospital admissions. This can also save up to $7.6bn in health costs annually. The savings would include $2.6 bn each year in medication errors, $2.3bn from improved care and prevention. There will be a reduction in unnecessary lab tests by more than 7.3 million, X rays by over 3 million.
Cameron Health, Inc. today announced the commencement of the company's pivotal clinical trial to gain U.S. approval of its Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The S-ICD System is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 5 days ago
| Entity Name | Advanced Ear Nose And Throat Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073655882 PECOS PAC ID: 2860443322 Enrollment ID: O20050202000598 |
News Archive
About 40 percent of Los Angeles County residents say they get no more than 10 minutes of continuous physical activity each week, according to a new report.
A major issue in the development of regenerative medicine is the cell sources used to rebuild damaged tissues.
In an analysis just released it is revealed that with an effective health IT system in place Australia would save up to 5,000 deaths and prevent two million GP and outpatient visits and 310,000 hospital admissions. This can also save up to $7.6bn in health costs annually. The savings would include $2.6 bn each year in medication errors, $2.3bn from improved care and prevention. There will be a reduction in unnecessary lab tests by more than 7.3 million, X rays by over 3 million.
Cameron Health, Inc. today announced the commencement of the company's pivotal clinical trial to gain U.S. approval of its Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The S-ICD System is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel A Mickelson, MD 960 Johnson Ferry Rd, Suite 200, Atlanta, GA 30342 Ph: (404) 943-0900 | Samuel A Mickelson, MD 960 Johnson Ferry Rd, Suite 200, Atlanta, GA 30342 Ph: (404) 943-0900 |
News Archive
About 40 percent of Los Angeles County residents say they get no more than 10 minutes of continuous physical activity each week, according to a new report.
A major issue in the development of regenerative medicine is the cell sources used to rebuild damaged tissues.
In an analysis just released it is revealed that with an effective health IT system in place Australia would save up to 5,000 deaths and prevent two million GP and outpatient visits and 310,000 hospital admissions. This can also save up to $7.6bn in health costs annually. The savings would include $2.6 bn each year in medication errors, $2.3bn from improved care and prevention. There will be a reduction in unnecessary lab tests by more than 7.3 million, X rays by over 3 million.
Cameron Health, Inc. today announced the commencement of the company's pivotal clinical trial to gain U.S. approval of its Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The S-ICD System is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.
› Verified 5 days ago
David Wei-hau Chou, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3200 Downwood Cir Nw Ste 640, Atlanta, GA 30327 Phone: 404-778-6880 | |
Dr. Peter Jay Abramson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5673 Peachtree Dunwoody Rd, Ste 150, Atlanta, GA 30342 Phone: 404-297-1780 Fax: 404-252-7255 | |
Dr. Michael Douglas Hellstrom, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 20 Glenlake Pkwy, Kaiser Permanente Medical Group Glenlake, Atlanta, GA 30328 Phone: 404-365-0966 Fax: 864-716-7738 | |
Donald Patrick Dennis, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 3193 Howell Mill Rd, #215, Atlanta, GA 30327 Phone: 404-355-1312 Fax: 404-352-2798 | |
Dr. Clementino Arturo Solares, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne Ste 1135, Atlanta, GA 30308 Phone: 404-778-3381 Fax: 216-445-9409 | |
Wiley A Parker, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5669 Peachtree Dunwoody Rd N, Ste 295, Atlanta, GA 30342 Phone: 404-256-9822 Fax: 404-256-0250 | |
Sarah K Wise, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Emory Department Of Otolaryngology, 1365a Clifton Road Ne, Suite A2300, Atlanta, GA 30322 Phone: 404-778-3381 |